» Articles » PMID: 38632579

Microbiota-derived Acetate Attenuates Neuroinflammation in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats

Overview
Publisher Biomed Central
Date 2024 Apr 17
PMID 38632579
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Increased neuroinflammation in brain regions regulating sympathetic nerves is associated with hypertension. Emerging evidence from both human and animal studies suggests a link between hypertension and gut microbiota, as well as microbiota-derived metabolites short-chain fatty acids (SCFAs). However, the precise mechanisms underlying this gut-brain axis remain unclear.

Methods: The levels of microbiota-derived SCFAs in spontaneously hypertensive rats (SHRs) were determined by gas chromatography-mass spectrometry. To observe the effect of acetate on arterial blood pressure (ABP) in rats, sodium acetate was supplemented via drinking water for continuous 7 days. ABP was recorded by radio telemetry. The inflammatory factors, morphology of microglia and astrocytes in rostral ventrolateral medulla (RVLM) were detected. In addition, blood-brain barrier (BBB) permeability, composition and metabolomics of the gut microbiome, and intestinal pathological manifestations were also measured.

Results: The serum acetate levels in SHRs are lower than in normotensive control rats. Supplementation with acetate reduces ABP, inhibits sympathetic nerve activity in SHRs. Furthermore, acetate suppresses RVLM neuroinflammation in SHRs, increases microglia and astrocyte morphologic complexity, decreases BBB permeability, modulates intestinal flora, increases fecal flora metabolites, and inhibits intestinal fibrosis.

Conclusions: Microbiota-derived acetate exerts antihypertensive effects by modulating microglia and astrocytes and inhibiting neuroinflammation and sympathetic output.

Citing Articles

Research progress of traditional Chinese medicine regulating intestinal flora in the treatment of hypertension.

Chen W, Xiao L, Guo W, Li H, Chen R, Duan Z Front Pharmacol. 2024; 15:1449972.

PMID: 39717555 PMC: 11664361. DOI: 10.3389/fphar.2024.1449972.

References
1.
Liu J, Li H, Gong T, Chen W, Mao S, Kong Y . Anti-neuroinflammatory Effect of Short-Chain Fatty Acid Acetate against Alzheimer's Disease via Upregulating GPR41 and Inhibiting ERK/JNK/NF-κB. J Agric Food Chem. 2020; 68(27):7152-7161. DOI: 10.1021/acs.jafc.0c02807. View

2.
Luo X, Han Z, Kong Q, Wang Y, Mou H, Duan X . Prevents Dysbiosis and the Rise in Blood Pressure in Spontaneously Hypertensive Rats. Int J Mol Sci. 2023; 24(5). PMC: 10002514. DOI: 10.3390/ijms24054955. View

3.
Sharma R, Yang T, Oliveira A, Lobaton G, Aquino V, Kim S . Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension. Circ Res. 2019; 124(5):727-736. PMC: 6395495. DOI: 10.1161/CIRCRESAHA.118.313882. View

4.
Virwani P, Qian G, Hsu M, Pijarnvanit T, Cheung C, Chow Y . Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring. Hypertension. 2023; 80(6):1331-1342. PMC: 10191209. DOI: 10.1161/HYPERTENSIONAHA.122.20752. View

5.
Durgan D, Ganesh B, Cope J, Ajami N, Phillips S, Petrosino J . Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension. Hypertension. 2015; 67(2):469-74. PMC: 4713369. DOI: 10.1161/HYPERTENSIONAHA.115.06672. View